Understanding the JC Virus and the Risks for MS Patients Learn how an extremely common and normally harmless virus may put certain multiple sclerosis patients at risk for some dangerous complications and what you should discus with your doctor before starting treatment.
"I am always concerned for the PML risk" this new study shocks me at how fast you can develop from JVC- to JCV+" ~Lynne A case of progressive multifocal leukoencephalopathy (PML) associated with natalizumab (Tysabri, Biogen) therapy has been reported in a patient with multiple sclerosis (MS) who***** had tested negative for JC virus (JCV) antibodies just 2 weeks before symptoms developed.**** 1-15-2016
Possible JC Virus Vaccination Offers Important Implications for MS Treatment
Researchers reveal possible new treatment methods for a rare, usually fatal brain disease.The JC virus, a member of the polyoma tumor virus family, was first isolated from the brain of a patient who was suffering from a rare brain disease known as progressive multifocal leukoencephalopathy (PML). Antibodies in PML patients often fail to recognize the JC virus they are infected with.
What Is the JC Virus? The John Cunningham virus, known more commonly as the JC virus, is a very common virus in the United States. According to the World Journal of Neurosciences, between 70 and 90 percent of people in the world have the virus. The average person carrying the JC virus will never know and is unlikely to suffer any side effects as a result of its being in his or her body. However, for a small percentage of individuals with multiple sclerosis (MS), that is not the case. The…
New Mouse Model Better Represents JC Virus That Infects MS Patients